Direct Therapeutics Awarded SBIR Grant
(Business Wire)Direct Therapeutics Inc.,, a privately-held drug development company, today announced that the National Institutes of Health has awarded the company a Small Business Innovation Research grant for the development of techniques to evaluate the distribution of its DTI-015 product candidate for the treatment of brain tumors.- Jun 11 5:24 PM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010611/0601.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines